Announcements Trials
Browse Landscape

Status

Recruiting 49Completed 45Not yet recruiting 23Unknown 14Active not recruiting 9Terminated 7Enrolling by invitation 4Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 17Surveys and Questionnaires 14Psychiatric Rehabilitation 7Therapeutics 6Polymerase Chain Reaction 5Interviews as Topic 5Immunohistochemistry 5Gene Expression Profiling 5Biopsy 5Radiotherapy 4Magnetic Resonance Spectroscopy 4High-Energy Shock Waves 4Reverse Transcriptase Polymerase Chain Reaction 3Microarray Analysis 3Fluorodeoxyglucose F18 3Abiraterone Acetate 3Watchful Waiting 2Standard of Care 2Specimen Handling 2Prednisone 2Methods 2Leuprolide 2In Situ Hybridization, Fluorescence 2Hematologic Tests 2Glucose Tolerance Test 2Drug Therapy 2Comparative Genomic Hybridization 2Chemotherapy, Adjuvant 2Biopsy, Fine-Needle 2Bariatric Surgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Observational × Observation × Clear all
NCT05292443 2024-02-23

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Geneplus-Beijing Co. Ltd.

Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡